Risk of excessive macular thinning in diabetic macular edema with ellipsoid zone disruption treated with anti-VEGF: 2-year real-world evidence.

چکیده

This study investigates whether different morphological features affect the best-corrected visual acuity (BCVA) and central macular thickness (CMT) in patients with diabetic macular edema (DME) undergoing anti–vascular endothelial growth factor (anti-VEGF) therapy. We retrospectively collected data…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• رتینوپاتی دیابتی